AVANOS MEDICAL, INC. (AVNS): Completion of Acquisition or Disposition of Assets
AVANOS MEDICAL, INC. (AVNS) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.1 4 avnsform8k_07272026xex101.htm EX-10.1 Document Execution Version CREDIT AGREEMENT dated as of July 27, 2026 among A-AV MERGERSUB, INC., as the Initial Borrower, AVANOS MEDICAL, INC., as the Borrower Representative, A-AV ACQUIRECO, INC., as a Borrower, A-AV INTERMEDIATEC
How this was made
The 30-second read
Why it matters
Completion plus new/updated credit documentation can affect capital structure and covenant headroom, but the excerpt does not provide transaction economics or how proceeds were used.
Market read
This is a primary-source filing confirming transaction completion, but the excerpt lacks the deal terms needed to gauge magnitude.
What to watch
Traders should look for the missing schedules and exhibits (e.g., disposition assets, consideration, and any debt issuance/repayment amounts) to assess leverage and earnings impact.
Background
The SEC 8-K reports Item 2.01 completion of an acquisition or disposition of assets, plus related material definitive agreement entries/terminations and a credit agreement exhibit.
Ticker impact
Avanos Medical filed an 8-K stating completion of an acquisition or disposition of assets and entry into related credit agreements.
Near-term price impact is likely limited unless the omitted schedules disclose deal size, proceeds, or accounting treatment.
The provided text is largely boilerplate credit-agreement structure; it confirms transaction completion but does not include deal economics or financial impact details.
Market effects
Limited sector read-through because the filing excerpt does not disclose the asset type or strategic rationale.
None indicated.
None indicated.
Counterpoint
Completion of an asset transaction may already be priced in if the market anticipated it; without deal-size/proceeds details, the incremental signal may be small.
Key entities
- issuerAVANOS MEDICAL, INC.
Subject of the 8-K, reporting completion of an acquisition/disposition and related financing documentation.
- transaction partyA-AV MERGERSUB, INC.
Initial borrower entity named in the credit agreement exhibit.
- lenderALLY BANK
Revolving administrative agent, swingline lender, and L/C issuer named in the credit agreement exhibit.
